Yahoo Finance7d
GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares
(Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline. The British drugmaker boosted its 2031 ...
IBTimes UK5d
Despite Profit Fallout, GSK Remains Optimist For 2031 Revenue Target Amidst Cancer Drug Sale Rise
The company has placed a strong emphasis on expanding its cancer drug portfolio and specialty medicines. However, GSK's latest financial report comes amid a barrage of lawsuits, including a major ...
Express & Star7d
GSK lifts long-term sales targets on new drug pipeline
Operating profits dropped by 40% to £4 billion due to a £1.8 billion settlement following lawsuits linked to its former heartburn drug Zantac. GSK said it expects core operating profits to rise ...
Yahoo Finance7d
GSK lifts long-term sales targets on new drug pipeline
Pharmaceuticals giant GlaxoSmithKline (GSK.L) (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an ...
Yahoo Finance7d
GSK lifts long-term sales targets on new drug pipeline
Pharmaceuticals giant GlaxoSmithKline (GSK.L) (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” ...
Financial Post7d
GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares
(Bloomberg) — GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline. The British drugmaker boosted its 2031 sales ...